A federal appeals court is today due to again deliberate on whether it's possible to patent...

|By:, SA News Editor

A federal appeals court is today due to again deliberate on whether it's possible to patent isolated human genes in a case that will probably have wide ramifications for the development of medical tests and treatments. The case involves Myriad Genetics (MYGN), which holds patents - at the moment - that allow it to genetically screen those at risk of breast or ovarian cancer.